Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
VitaDAO 💛 Profile picture
VitaDAO 💛
@vita_dao
VitaDAO is a community owned collective funding early stage longevity research,governed by $VITA-holders 🧬 👉https://t.co/uq15UrsgHO
Apr 5, 2023 • 8 tweets • 2 min read
Lack of adequate funding has been the major culprit behind the stall of several longevity-related research.

In line with our goal to accelerate research assets in this season 0, one particular proposal stands out; it tackles this funding challenge head-on. Let's check it out! Image Many longevity-related research projects never see the light of day due to the enormous funding required for commercialization.

In the US, the required funding to advance to an FDA-ready IND stage varies between $3-5 million. This is currently beyond VitaDAO's funding scope.
Apr 5, 2023 • 10 tweets • 2 min read
SG 0.3b proposal breakdown⬇️

Molecule provides services to VitaDAO research projects and has historically been paid in cash from the VitaDAO treasury.

This proposal offers the VitaDAO community to pay Molecule's IP services in sweat equity, to protect VitaDAO's cash treasury.🧵 Image @Molecule_dao's offer includes a co-investment right to earn, through the provision of services, equity in IP-NFTs, instead of cash. This proposal aims to address the "Liquify Research Assets" goal from the VitaDAO 2023 Strategic Plan 3 and accelerate research assets.
Apr 4, 2023 • 5 tweets • 6 min read
📢 The 3rd Edition of the VitaDAO DeSci & Longevity Symposium is happening TOMORROW!

🔬 Join us from 10am - 5:30pm CET for the latest updates on Longevity Science and DeSci.

Discover the science behind slowing down aging and the development of rejuvenation therapies.

🧵👇 Let's meet the speakers:
• @longevion - @vita_dao
• @aubreydegrey - @LongevityEVF
• Prof. Vadim Gladyshev - @gladyshev_lab & @harvardmed
• @manveerbasra_ - @ScholarOrg
Apr 4, 2023 • 6 tweets • 3 min read
🤔Did you know that bats are one of the longest-lived mammals for their size?

Join us for an exciting talk by Prof. Emma Teeling (@EmmaTeeling1) on how studying bats can help us better understand the aging process and promote longevity. Image .@EmmaTeeling1 is a Professor in the School of Biology and Environmental Science at @ucddublin, where she leads the Laboratory of Molecular Evolution and Mammalian Phylogenetics (aka. the “Batlab”).

Her research focuses on understanding bat genomes and their evolution.
Apr 4, 2023 • 5 tweets • 3 min read
Why are our gametes so good at DNA repair when the rest of our cells aren’t?

Would it be possible to make the rest of our cells as efficient as gametes to prevent age-related diseases?

@ArBujarrabal will tackle these questions at the 3rd VitaDAO DeSci & Longevity Symposium Image @ArBujarrabal recently finished his PhD at the lab of Björn Schumacher (@schumacherbj) in @CECAD_.

His work has centered on DNA repair in development and ageing, resulting in this amazing paper: doi.org/10.1038/s41594…
Apr 3, 2023 • 6 tweets • 3 min read
Reproductive ageing goes beyond the loss of fertility. Can we change a woman’s life narrative of reproductive inevitability to reproductive longevity?

Dr. Zhongwei Huang will join us at The 3rd VitaDAO DeSci & Longevity Symposium to explore this important question. Image Dr. Zhongwei Huang is an internationally recognized in vitro fertilization expert, and is the Deputy Director of the Asia Centre for Reproductive Longevity and Equality (@ACRLE_NUS).

His work unravels the biology of ovarian folliculogenesis to achieve ovarian rejuvenation.
Jan 30, 2023 • 26 tweets • 24 min read
🤩 We are excited to announce that we've closed a $4.1m fundraising round🌱 from strategic members including:

• @pfizer Ventures
• @ShineCapitalNYC
• @L1Digital_
• @beakerdao
• @SpaceshipDAO
• @balajis
• @bettslacroix
and many more

🧵
forbes.com/sites/johncumb… The fundraise is an important milestone for VitaDAO and will allow the organisation to accelerate 🚀 its mission of extending human life and healthspan. ♾️
Sep 20, 2022 • 11 tweets • 4 min read
Introducing Decentralized Technology Transfer (DTT) - A Modern Framework to Empower Scientific Innovation🌱

Its purpose is to enable the researcher to operate outside of their institution and leverage other institutions’ resources.

Let’s break it down👇
vitadao.medium.com/decentralized-… The transfer of technology (TT) is essential in turning intellectual property (IP) generated from innovative research into real-world applications that benefit the general public.
Dec 17, 2021 • 4 tweets • 2 min read
3⃣proposals are live on-chain and you can vote with your $VITA Tokens!

👉VDP-14 Move Tier 3 Governance to Snapshot
👉VDP-16: Korolchuk Lab-Autophagy Activators Funding Proposal
👉VDP-17: CrowdFundedCures.org Partnership

Your vote counts as always! 👇
dao.vitadao.com/#/proposals
Dec 16, 2021 • 6 tweets • 3 min read
New article🔥VitaDAO x @CrowdFundedCure
by @newzealandlaw & @AriellaStudies

The patent system has a strange-hold on drug R&D, but is there a better way?👀 Learn about pay-for-success contracts using simple comics and a concrete example: rapamycin.

🧵/
vitadao.medium.com/a-new-financia… The sole reliance on the patent system to fund biopharma R&D is a major roadblock. Doctors, patients, investors, and health insurers could all benefit from a novel system to fund trials for "unmonopolisable" therapies like generic drugs and even diet/exercise regimes.

🧵2/
Dec 16, 2021 • 13 tweets • 3 min read
$VITA Voting Time!🗳

📣VDP-17: CrowdFundedCures.org Partnership Proposal is live on-chain

Crowd Funded Cures' mission is to implement pay-for-success smart contracts or social impact bonds (SIBs) to incentivise the repurposing of generic drugs

👉dao.vitadao.com/#/proposal/14

🧵/ Image 2/
The SIB mechanism incentivises impact investors (such as VitaDAO token holders) to fund IPNFTs holding encrypted Phase II/III randomised controlled trial (RCT) data to sell to payers in exchange for outcome payments...
Dec 14, 2021 • 9 tweets • 2 min read
$VITA Voting Time!🗳

📢 VDP-16: Korolchuk Lab-Autophagy Activators Funding Proposal is live on-chain.

Prof. Korolchuck lab proposes to initiate a drug discovery programme with the aim of identifying novel bioactive autophagy inducers.

👉dao.vitadao.com/#/proposal/13
🧵/ Image 2/
Ageing is associated with the decline in the capacity of the autophagy pathway to degrade dysfunctional and damaging cellular components, such as protein aggregates and mitochondria.
Aug 23, 2021 • 9 tweets • 3 min read
ALTERNATIVES to Government Grants and Big Pharma🧑‍🔬

Nonprofits attempt to fill this gap with some success, but philanthropy can only go so far.

There is little incentive to donate when donors do not have control of how their money is used...

1/🧵 2/
...or have any chance of financial benefit should the projects they fund become successful.

As a result, philanthropic donations are almost always limited to a very small portion of the donor’s wealth.
Jun 24, 2021 • 9 tweets • 4 min read
Are you new to longevity and want to learn more about the research? 🧬🔬

We made a thread for you!
Start here👇 The Purpose of Technology by @balajis balajis.com/the-purpose-of…